Nanotechnology-Boosted Biomaterials for Osteoarthritis Treatment: Current Status and Future Perspectives

Abstract

Osteoarthritis (OA) is a prevalent global health concern, posing a significant and increasing public health challenge worldwide. Recently, nanotechnology-boosted biomaterials have emerged as a highly promising strategy for OA therapy due to their exceptional physicochemical properties and capacity to regulate pathological processes. However, there is an urgent need for a deeper understanding of the potential therapeutic applications of these biomaterials in the clinical management of diseases, particularly in the treatment of OA. In this comprehensive review, we present an extensive discussion of the current status and future prospects concerning nanotechnology-boosted biomaterials for OA therapy. Initially, we discuss the pathophysiology of OA and the constraints associated with existing treatment modalities. Subsequently, various types of nanomaterials utilized for OA therapy, including nanoparticles, nanofibers, and nanocomposites, are thoroughly discussed and summarized, elucidating their respective advantages and challenges. Furthermore, we analyze recent preclinical and clinical studies that highlight the potential of nanotechnology-boosted biomaterials in OA therapy. Additionally, future research directions in this evolving field are highlighted. By establishing a link between the structural properties of nanotechnology-boosted biomaterials and their therapeutic functions in OA treatment, we aim to foster advances in designing sophisticated nanomaterials for OA, ultimately resulting in improved therapeutic efficacy of OA therapy through translation into clinical setting in the near future.

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment

“…It is only when these sectors work together that promising nanomedicines can reach the market and be applied to patients. 678 , 681 , 682 Therefore, more standardized policies and regulations are needed to ensure the clinical translation of nanomedicines.…”

Functional Nanomaterials for the Treatment of Osteoarthritis

“… 3 The pathophysiology of osteoarthritis (OA) is multifaceted and involves complex interactions between several factors, including cartilage degradation, chronic inflammatory responses, changes in subchondral bone structure, and atypical joint mechanics. 4 The key events in joint pathology during the progression of OA are shown in Figure 1A . In the initial phase, the joint space narrows, bony encumbrances appear, and chondrocytes enlarge and progressively break down, eventually leading to friction between bone ends.…”